Effectiveness and tolerability of a homoeopathic remedy compared with conventional therapy for mild viral infections

International Journal of Clinical Practice

Volumn 58, Issue 9, 2004, Pages 827-832

  Rabe, A ^a   Weiser, Michael ^a,b   Klein, P ^c  

^a Gaggenau ^*  (Germany)

^b Biologische Heilmittel Heel GmbH   (Germany)

^c Dsh Statistical Services GmbH   (Germany)

Author keywords

Anti tussive; Cohort study; Compliance; Gripp Heel; NSAID

Indexed keywords

ACONITUM EXTRACT; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; BRYONIA DIOICA EXTRACT; ECHINACEA EXTRACT; EUPATORIUM PERFOLIATUM EXTRACT; EXPECTORANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHORUS; PLANT EXTRACT; SNAKE VENOM; UNCLASSIFIED DRUG;

ACONITUM; ADULT; AGED; ALLERGIC REACTION; ANTIVIRAL ACTIVITY; ARTICLE; BRYONIA; CLINICAL OBSERVATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ECHINACEA; EUPATORIUM; EUPATORIUM PERFOLIATUM; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH PRACTITIONER; HOMEOPATHY; HUMAN; HUMORAL IMMUNITY; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; PATIENT COMPLIANCE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SORE THROAT; SYMPTOMATOLOGY; VIRUS INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTITUSSIVE AGENTS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HOMEOPATHY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 7744229113     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00150.x     Document Type: Article

References (27)

1. Heikkinen T, Jarvinen A. The common cold. Lancet 2003; 361: 51-9.
2. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33: 757-62.
3. Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci USA 1971; 68: 2678-81.
4. Douglas RM, Chalker EB, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2000. CD000980.
5. Vitetta L, Sali A, Paspaliaris B, Reavley NJ. Megadose vitamin C in treatment of the common cold: a randomised controlled trial. Med J Aust 2002; 176: 298-9.
6. Audera C, Patulny RV, Sander BH, Douglas RM. Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial. Med J Aust 2001; 175: 359-62.
7. Smith MB, Feldman W. Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 1993; 269: 2258-63.
8. Lowenstein SR, Parrino TA. Management of the common cold. Adv Intern Med 1987; 32: 207-33.
9. Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2001. CD001831.
10. Sperber SJ, Hendley JO, Hayden FG et al. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann Intern Med 1992; 117: 37-41.
11. Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhino-virus colds. Bull N Y Acad Med 1989; 65: 145-60.
12. Marshall I. Zinc for the common cold. Cochrane Database Syst Rev 2000. CD001364.
13. The Homeopathic Pharmacopoeia of the United States (HPUS), 8th edn. Falls Church, VA: 1979.
14. Rosenbaum P. The central role of the propensity score in observational studies for causal effects. Biometrica 1983; 70: 41-55.
15. Fleiss J. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons, 1996, pp. 224-41.
16. Siewierska K, Denys A. Efficacy of preoperative immunoprophylaxis in patients with neoplastic diseases. Int Rev Allergol Clin Immunol 1999; 5: 39-44.
17. Denys A, Siwierska K. Efficacy of preopreative immunoprophylaxis in patients with neoplastic diseases. Int Rev Allergol Clin Immunol 1999; 5: 46-50.
18. Brydak L, Denys A. The evaluation of humoral response and the clinical evaluation of a risk-group patients' state of health after administration of the homeopathic preparation Gripp-Heel during the influenza epidemic season 1993/94. Int Rev Allergol Clin Immunol 1999; 5: 223-7.
19. Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ 2002; 324: 329-31.
20. Conforti A, Bertani S, Metelmann H et al. Experimental studies of the anti-inflammatory activity of a homeopathic preparation. Biol Ther 1997; 15: 28-31.
21. Appendino G, Szallasi A. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci 1997; 60: 681-96.
22. Ordinatio Antihomotoxica et Materia Medica, 5th revised English edn. Bühl, Germany: Konkordia Druck GmbH, 2000.
23. Turner RB. Echinacea for the common cold: can alternative medicine be evidence-based medicine? Ann Intern Med 2002; 137: 1001-2.
24. De Smet PA. Herbal remedies. N Engl J Med 2002; 347: 2046-56.
25. European Commission. Directive on traditional herbal medicinal products. Amendment to Directive 2001/83/EC. Brussels: Commission of the European Communities, 2002.
26. Talalay P, Talalay P. The importance of using scientific principles in the development of medicinal agents from plants. Acad Med 2001; 76: 238-47.
27. Marcus D, Grollman A. Botanical medicines - the need for new regulations. N Engl J Med 2002; 347: 2073-5.